Compare Cytokinetics Inc (CYTK) vs Upstart Holdings Inc (UPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Upstart Holdings Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Upstart Holdings Inc trades at $29.89 (market cap $2.91B). The key difference: Cytokinetics Inc is far larger — about 3.7× Upstart Holdings Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Upstart Holdings Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | UPST | |
|---|---|---|
Market Cap | $10.63B | $2.91B |
Sector | Technology | Financials |
52-Week High | $87.26 | $73.76 |
52-Week Low | $34.31 | $24.22 |
Enterprise Value | $10.74B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Upstart Holdings Inc
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →
